Introduction
Pregnancy-induced hypertension (PIH) is a common and serious complication of pregnancy. There is persuasive evidence implicating genetic factors in the genesis of PIH ( 1 ) . Genetic association studies have shown both positive ( 2 -4 ) and negative ( 5 , 6 ) associations between PIH and genetic factors. Very few genes with a potential causative role in PIH have been identified. Gain of body weight in pregnancy period (kg)
9.1 ± 6.9
9.7 ± 4. Steroid hormones regulate a wide range of cellular events by activating a receptor family of transcription factors. Estrogens, which are steroid hormones, can have systemic effects, including effects on the brain, heart, liver, and cardiovascular system ( 7 ). Effects of estrogens on their target tissues occur via activation of one or both of the two estrogen receptors, ER α (ESR1) and ER β (ESR2), which are members of the nuclear receptor superfamily ( 8 , 9 ) . Both receptors are expressed in a wide range of tissues, including macrophages, vascular smooth muscle, and vascular endothelial cells ( 10 ) .
Estrogen receptors have been studied intensely within the field of female reproductive physiology. Recently, the function of estrogen receptors in both genders has been studied, especially with regard to cardiovascular diseases. Accumulating evidence derived from clinical, epidemiological, and experimental studies suggests that estrogen deficiency plays a major role in the pathogenesis of cardiovascular diseases such as hypertension in postmenopausal women ( 11 , 12 ) . Estrogen receptors are necessary and sufficient for estrogen-mediated protection against vascular injury ( 13 , 14 ) . The plasma level of estrogen is markedly increased during pregnancy, suggesting that dysfunction of ESR1 is involved in PIH. There have been no reports of studies of association between PIH and the ESR1 gene.
The aim of the present work was to assess the association between PIH and single-nucleotide polymorphisms (SNPs) in the human ESR1 gene by conducting a haplotype-based casecontrol study.
Methods

Subjects
PIH is defined as hypertension, with or without proteinuria, occurring after the 20th week of gestation but resolving by the 12th week postpartum. PIH is classified into 4 categories: 1) preeclampsia (PE), 2) gestational hypertension (GH), 3) superimposed PE, and 4) eclampsia. PE is defined as hypertension with proteinuria occurring after the 20th week of gestation but resolving by the 12th week postpartum. GH is defined as hypertension without proteinuria occurring after the 20th week of gestation but resolving by the 12th week postpartum. These criteria are compatible with the fundamental characteristics of PIH established by the International Society for the Study of Hypertension in Pregnancy (ISSHP) ( 15 ) .
The PIH group comprised 95 pregnant Japanese women with PIH (median age, 31 years; age range, 17 to 46 years). Subjects were diagnosed with PIH if they had a systolic blood pressure (SBP) of ≥ 140 mmHg or a diastolic blood pressure (DBP) of ≥ 90 mmHg, with or without proteinuria. The SBP and DBP values used for diagnosis were the maximal values recorded during the patient evaluations. All PIH patients were normotensive before 20 weeks of gestation, and their blood pressure returned to normal in the puerperium. PIH was considered severe if any of the following were observed: SBP ≥ 160 mmHg; DBP ≥ 110 mmHg; proteinuria ( ≥ 2.0 g in 24 h
or ≥ 2+ upon qualitative examination). We recorded the highest blood pressure measured during pregnancy without uterine contraction. When a subject was diagnosed with PIH, blood pressure was measured again under resting conditions. Proteinuria was defined as > 300 mg per 24 h or 1+ with dipstick. The PIH group was divided into two subgroups: PE and GH (Table 1 ) ( 16 ). The non-PIH group (controls) comprised 200 pregnant Japanese women without PIH (median age, 30 years; age range, 17 to 46 years). These non-PIH controls had not previously participated in any other study. All 295 subjects (PIH and non-PIH groups) lived in the Kanto district of Japan, and were recruited from among patients and healthy volunteers at Nihon University Hospital, in Tokyo, Japan. Primigravidae comprised 38.9% of the PIH cases and 38.5% of the non-PIH controls. Among the PIH women who were multigravidae, 18 (50.0%) had suffered from PIH in previous pregnancies. There was a family history of hypertension in 35.8% of the PIH cases and in 19.0% of the non-PIH controls. Informed consent was obtained from each subject according to a protocol approved by the Human Studies Committee of Nihon University, Japan ( 6 ).
Genotyping
Based on information from the National Center for Biotechnology Information (NCBI) database web site or from the Celera Discovery System (CDS), we chose SNPs with a minor allele frequency of > 30%. Reference SNP cluster (rs) IDs are created by NCBI during periodic "builds" of the database. We selected five SNPs in the human ESR1 gene, and assessed the association between those SNPs and the PIH and non-PIH groups. One SNP was located in the 5 ′ flanking region of the ESR1 gene; three SNPs were located in an intron; and one SNP was located in the 3 ′ untranslated region of the ESR1 gene ( Fig. 1 ).
Blood samples were collected from all participants, and genomic DNA was extracted from the peripheral blood Fig. 1 mononuclear cells using standard procedures ( 17 ) . Genotypes were determined using Assays-on-Demand kits (Applied Biosystems, Branchburg, USA) together with TaqMan PCR as previously described ( 18 ) .
Statistical Analysis
Data are presented as the means ± SD. Hardy-Weinberg equilibrium was assessed by performing χ 2 analysis. The overall distribution of alleles was analyzed using 2 × 2 contingency tables, and the distributions of the genotypes between PIH patients and non-PIH subjects were tested using a 2-sided Fisher exact test and multiple logistic regression analysis. PIH was regarded as the dependent variable, while genotypes and age were considered the independent variables. We also analyzed the overall distributions of alleles and genotypes between PE patients and non-PIH subjects, and between GH patients and non-PIH subjects. A probability level of p < 0.05 was considered to indicate statistical significance.
Based on the genotype data of the genetic variations, we performed a linkage disequilibrium (LD) analysis and a haplotype-based case-control study using the expectation maximization (EM) algorithm ( 19 , 20 ) of the SNPAlyze ™ software program, version 3.2 (Dynacom Co., Ltd., Yokohama, Japan) ( 16 ). A pair-wise LD analysis was performed using four SNP pairs. D ′ values of > 0.5 were used to assign SNP locations to one haplotype block. Tagged SNPs were selected by omitting one SNP from an SNP pair with an r 2 of > 0.5 for each haplotype block. In this haplotype-based casecontrol study, haplotypes with a frequency of < 0.03 were excluded. The distribution of haplotype frequencies was calculated using the χ 2 test ( 19 ) . A probability level of p < 0.05 was considered to indicate statistical significance. Statistical analyses were performed using SPSS ™ software for Windows, version 12 (SPSS Inc., Chicago, USA) ( 21 ) .
Results
The clinical characteristics of the 95 PIH patients and 200 non-PIH subjects are shown in Table 1 . Body mass index (BMI) before pregnancy, BMI immediately before delivery, SBP, and DBP were significantly higher in the PIH group than in the non-PIH group. The gestational weeks at pregnancy, birth weight of neonates, and Apgar score were significantly lower in the PIH group than in the non-PIH group. The frequency of family history of hypertension was significantly higher in the PIH than in the non-PIH group. There were no significant differences in age, the frequency of primigravidas or the gain of body weight during the pregnancy period between the PIH and non-PIH groups. Because BMI before pregnancy was significantly higher in the PIH group than in the non-PIH group, we also included an additional non-PIH group (130 subjects) that was matched not only for age but also for BMI before pregnancy.
We performed an association analysis using the five SNPs ( Table 2 ). The genotype and allele frequency of rs2881766 differed significantly between the non-PIH group and PIH group. The T allele of rs2881766 was significantly more prevalent in the PIH group than in the non-PIH group ( p = 0.003). The results showed significant difference when the threshold of significance was set at 0.01 (with Bonferroni's correction for the five SNPs). These results were the same as those of the additional case-control analysis using the BMI-matched control group.
Although the genotype frequency of rs988328 differed significantly between the non-PIH group and the PE subgroup, there was no significant difference in its frequency between the non-PIH group (all) and the PIH group.
The patterns of LD in the ESR1 gene are shown with their D ′ and r 2 values (Fig. 2) . The three SNPs of rs2881766, rs1643821 and rs988328 were located in one haplotype block; the other two SNPs were not located in this haplotype block. Because all r 2 calculated for the three SNPs rs2881766, rs1643821 and rs988328 were small, we constructed a haplotype-based association study using rs2881766, rs1643821 and rs988328 (Table 3 ). There was a significant difference in the overall distribution of the combination of rs2881766-rs1643821-rs988328, rs2881766-rs1643821, and rs2881766- rs988328 between the PIH group and the non-PIH (all) control group. There was a significant difference in the overall distribution of the combinations rs2881766-rs1643821-rs988328 and rs2881766-rs1643821 between the PIH group and the non-PIH (BMI matched) control group. There was one susceptibility haplotype (T-A constructed with rs2881766-rs1643821) and three resistance haplotypes (G-A-T constructed with rs2881766-rs1643821-rs988328, G-A constructed with rs2881766-rs1643821, G-T constructed with rs2881766-rs988328) for PIH between the PIH group and the non-PIH (all) control group. There were also significant differences in two of the resistance haplotypes (G-A-T, G-A) between the PIH group and the non-PIH (BMImatched) control group. One susceptibility haplotype (G-G-T constructed with rs2881766-rs1643821-rs988328) was revealed by comparison between the PIH group and the non-PIH (BMI-matched) control group ( p = 0.030).
Discussion
Although it is widely known that estrogen plays a very important role in the regulation of blood pressure, the details of the mechanisms involved are unclear. There have been many reported studies of an association between estrogen and blood pressure. Gender differences in blood pressure control have been observed in both animals and humans, and those differences often appear to be due to differences in sex hormones.
Male humans and rats have higher blood pressure than females of those species, suggesting that female hormones play a role in protecting females from developing high blood pressure. In women, menopause is characterized by increases in blood pressure, as shown by a large-scale cohort study (NHANES III study) and other studies ( 22 -24 ). Han et al . reported that estrogen inhibits Ca 2+ influx and Ca 2+ release in porcine coronary vascular smooth muscle, suggesting that estrogen has Ca 2+ channel blocker-like activity ( 25 ). Morey et al . ( 26 ) were the first to report that estrogen inhibits vascular smooth muscle proliferation via endothelin 1 activity. Some investigators have found that this inhibitory function of estrogen is mediated by endothelin 1 via an estrogen receptor or another mechanism. The above-mentioned results suggest that estrogen engages several mechanisms that protect against hypertension. Studies of hormone replacement therapy (HRT) also suggest that estrogen plays a role in hypertension in women (12) .
The plasma level of estrogen is markedly increased in nor- mal pregnancy, compared to the non-pregnant state, because estrogen is produced by the embryo and placenta. Although estrone and estradiol levels increase 100 times and estriol levels increase 1,000 times during pregnancy, blood pressure remains within the normal range during normal pregnancy ( 27 ) . The estrogen receptor ESR1 activates specific target genes in vascular smooth muscle, inhibits smooth muscle cell migration, and accelerates endothelial cell growth in vitro and in vivo ( 13 ) . In addition, fewer ESR1 molecules are found in premenopausal women with atherosclerotic coronary arteries than in those with normal arteries ( 11 , 12 ) . It is possible that the effects of estrogen on vascular cells are mediated by ESR1. Thus, dysfunction of ESR1 in pregnancy may induce cardiovascular disorders such as hypertension, including PIH. The PIH-associated allele, genotype and haplotype identified in the present study may represent functional mutations in the ESR1 gene that are involved in the pathophysiology of PIH.
Because it has been reported that ESR2-knockout mice exhibit hypertension resulting from a change in blood vessel contraction ( 28 ), we previously investigated whether ESR2 is a promising candidate gene of PIH ( 29 ) . Although there were no significant differences in allelic distribution of SNPs in ESR2 between PIH subjects and normal controls, we found a significant difference in the allele frequencies of one SNP between PE subjects with and without a family history of hypertension. These results suggest that ESR1 is more likely to be a susceptibility gene of PIH than is ESR2.
Although it was reported that ESR1 gene variants confer a substantially increased risk of myocardial infarction ( 30 , 31 ) , there have been no reports showing a positive association between the ESR1 gene and PIH. Malamitsi-Puchner et al . ( 32 ) sequenced exon 1 and exon 2 of the ESR1 gene, using 16 PIH patients and 20 normal pregnant women (controls). They found two synonymous (non-functional) SNPs (rs2077647 and rs746432) in exon 1. The allelic distribution of these two SNPs did not significantly differ between their PIH and control groups. In the present study, we did not include the SNPs rs2077647 and rs746432, and instead evaluated five other SNPs as genetic markers. Those five SNPs appear to be good markers in strong LD with other mutations of the ESR1 gene that have strong effects on ESR1 activity and are responsible for PIH, because the minor allele frequencies of all five SNPs were > 40%.
It has been reported that overweight is a strong risk factor for PIH. Incidence of both mild and severe PIH rises with increasing BMI ( 33 , 34 ) . Because in the present study BMI before pregnancy was significantly higher in the PIH group than in the non-PIH group, we performed additional casecontrol analysis using a BMI-matched non-PIH group. In both case-control analyses, the T allele of rs2881766 appeared to be a marker for PIH. These results indicate that this allele is a marker for PIH with no association with BMI. Although the overall distributions of the haplotype-based case-control analysis showed significant differences for rs2881766-rs1643821-rs988328 and rs2881766-rs1643821, the results of susceptibility haplotypes for PIH (G-G-T constructed with rs2881766-rs1643821-rs988328 and T-A constructed with rs2881766-rs1643821) differed between the two analyses. The resistance haplotypes, G-A-T constructed with rs2881766-rs1643821-rs988328 and G-A constructed with rs2881766-rs1643821, showed the same results for both analyses, with statistically significant differences. This discrepancy in results between the two analyses appears to depend on the number of subjects in the case-control study. However, we believe that the consistent results for overall distribution in the two haplotype-based case-control analyses provide valuable information about these haplotypes, and they suggest that the ESR1 gene is a susceptibility gene for PIH.
Morris et al . found that, in genes with multiple susceptibility alleles, analysis based on haplotypes can have advantages over analysis based on individual SNPs, particularly when the LD between SNPs are weak ( 35 ) . This finding should encourage further development of statistical methods based on haplotypes, to assess the potential of association methods to identify and locate complex disease genes. Some specific haplotype combinations in functional regions such as promoters or exons affect disease genesis. Positions of some susceptibility genes of multifactorial diseases have been identified using haplotype analysis ( 18 ) . Based on such findings, we hypothesized that haplotype analysis would be useful for assessing the association between haplotypes and PIH, resulting in the present attempt to establish haplotypes of the ESR1 gene consisting of SNPs.
Although certain factors such as smoking and diabetes mellitus are recognized as risk factors for PIH, these factors were not included in the present study. Further studies will be needed to perform case-control association analyses that include the risk factors for PIH in larger numbers of subjects. In conclusion, we found that the T allele of rs2881766 can be a useful genetic marker of PIH, and that the G-A-T haplotype of rs2881766-rs1643821-rs988328 and the G-A haplotype of rs2881766-rs1643821 appear to be resistance markers of PIH.
